Declined adipogenic potential of senescent MSCs due to shift in insulin signaling and altered exosome cargo.

MSCs (mesenchymal stromal cells) adipogenic potential extracellular vesicles (EVs) insulin signaling senescence

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2022
Historique:
received: 21 09 2022
accepted: 02 11 2022
entrez: 5 12 2022
pubmed: 6 12 2022
medline: 6 12 2022
Statut: epublish

Résumé

Multipotent mesenchymal stromal cells (MSCs) maintain cellular homeostasis and regulate tissue renewal and repair both by differentiating into mesodermal lineage, e.g., adipocytes, or managing the functions of differentiated cells. Insulin is a key physiological inducer of MSC differentiation into adipocytes, and disturbances in MSC insulin sensitivity could negatively affect adipose tissue renewal. During aging, regulation and renewal of adipose tissue cells may be disrupted due to the altered insulin signaling and differentiation potential of senescent MSCs, promoting the development of serious metabolic diseases, including metabolic syndrome and obesity. However, the potential mechanisms mediating the dysfunction of adipose-derived senescent MSC remains unclear. We explored whether aging could affect the adipogenic potential of human adipose tissue-derived MSCs regulated by insulin. Age-associated senescent MSCs (isolated from donors older than 65 years) and MSCs in replicative senescence (long-term culture) were treated by insulin to induce adipogenic differentiation, and the efficiency of the process was compared to MSCs from young donors. Insulin-dependent signaling pathways were explored in these cells. We also analyzed the involvement of extracellular vesicles secreted by MSCs (MSC-EVs) into the regulation of adipogenic differentiation and insulin signaling of control and senescent cells. Also the microRNA profiles of MSC-EVs from aged and young donors were compared using targeted PCR arrays. Both replicatively and chronologically senescent MSCs showed a noticeably decreased adipogenic potential. This was associated with insulin resistance of MSCs from aged donors caused by the increase in the basal level of activation of crucial insulin-dependent intracellular effectors ERK1/2 and Akt. To assess the impact of the paracrine cross-talk of MSCs, we analyzed microRNAs profile differences in MSC-EVs and revealed that senescent MSCs produced EVs with increased content of miRNAs targeting components of insulin-dependent signaling cascade PTEN, MAPK1, GAREM1 and some other targets. We also confirmed these data by differentiation of control MSCs in the presence of EVs from senescent cells and

Identifiants

pubmed: 36467400
doi: 10.3389/fcell.2022.1050489
pii: 1050489
pmc: PMC9714334
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1050489

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 Voynova, Kulebyakin, Grigorieva, Novoseletskaya, Basalova, Alexandrushkina, Arbatskiy, Vigovskiy, Sorokina, Zinoveva, Bakhchinyan, Kalinina, Akopyan, Tkachuk, Tyurin-Kuzmin and Efimenko.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Sci Rep. 2015 May 22;5:9930
pubmed: 26001136
J Cell Biol. 2011 Feb 21;192(4):547-56
pubmed: 21321098
Nature. 2011 Nov 02;479(7372):232-6
pubmed: 22048312
Nature. 2006 Jun 29;441(7097):1080-6
pubmed: 16810243
Nat Med. 2015 Dec;21(12):1424-35
pubmed: 26646499
Ageing Res Rev. 2011 Jan;10(1):146-52
pubmed: 20946972
J Cell Biol. 2018 Jan 2;217(1):65-77
pubmed: 29114066
Adv Drug Deliv Rev. 2013 Mar;65(3):368-75
pubmed: 22820533
Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E898-906
pubmed: 19638508
Nat Med. 2009 Sep;15(9):1082-7
pubmed: 19718037
Cells. 2020 May 20;9(5):
pubmed: 32443855
Front Physiol. 2015 Dec 02;6:362
pubmed: 26696897
Mol Cell Endocrinol. 2010 Mar 25;316(2):129-39
pubmed: 19723556
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
J Gerontol A Biol Sci Med Sci. 2014 Jan;69(1):13-24
pubmed: 23657974
Eur Heart J. 2008 Dec;29(24):2959-71
pubmed: 18775919
Exp Biol Med (Maywood). 2018 Jul;243(11):911-916
pubmed: 29950119
Endocrinology. 2021 Oct 1;162(10):
pubmed: 34363464
Aging Cell. 2010 Oct;9(5):667-84
pubmed: 20701600
Physiol Rev. 2018 Oct 1;98(4):1911-1941
pubmed: 30067159
Aging Cell. 2019 Jun;18(3):e12950
pubmed: 30907060
Cell Metab. 2014 Dec 2;20(6):1049-58
pubmed: 25456741
Aging Dis. 2021 Feb 1;12(1):102-115
pubmed: 33532131
Mol Biol Rep. 2020 Jun;47(6):4587-4629
pubmed: 32333246
Aging (Albany NY). 2018 May 19;10(5):1103-1132
pubmed: 29779019
Biomolecules. 2020 Feb 21;10(2):
pubmed: 32098040
EBioMedicine. 2019 Sep;47:446-456
pubmed: 31542391
Acta Naturae. 2018 Jan-Mar;10(1):4-14
pubmed: 29713514
Mol Aspects Med. 2018 Apr;60:92-103
pubmed: 29146100
PLoS One. 2009 Jul 10;4(7):e6189
pubmed: 19593385
Nat Rev Mol Cell Biol. 2008 May;9(5):367-77
pubmed: 18401346
Nature. 2014 May 22;509(7501):439-46
pubmed: 24848057
Mol Cell Endocrinol. 2017 Nov 5;455:93-102
pubmed: 27591120
Stem Cell Res Ther. 2018 Sep 26;9(1):257
pubmed: 30257725
Stem Cells Transl Med. 2014 Jan;3(1):32-41
pubmed: 24353175
Mol Cell Biochem. 2018 Dec;449(1-2):295-303
pubmed: 29959592
Nat Med. 2022 Aug;28(8):1556-1568
pubmed: 35953721
J Biol Chem. 2021 Aug;297(2):100968
pubmed: 34273354
Diabetes. 2010 Jan;59(1):105-9
pubmed: 19846802
J Cell Physiol. 2016 Mar;231(3):587-96
pubmed: 26206105
Nat Commun. 2019 Jun 21;10(1):2757
pubmed: 31227697
Front Cell Dev Biol. 2020 May 05;8:258
pubmed: 32478063
Wiley Interdiscip Rev RNA. 2014 Sep-Oct;5(5):697-712
pubmed: 24944010
Adipocyte. 2018;7(2):96-105
pubmed: 29411671
Genes Dev. 2009 Dec 15;23(24):2839-49
pubmed: 20008935
Int J Obes (Lond). 2015 Aug;39(8):1282-91
pubmed: 25817070
ScientificWorldJournal. 2012;2012:793823
pubmed: 22500143
Nature. 2008 Jun 5;453(7196):783-7
pubmed: 18454136
Nature. 2019 Jul;571(7764):183-192
pubmed: 31292558
Front Cell Dev Biol. 2020 Sep 25;8:576176
pubmed: 33102483
Stem Cells. 2018 Mar;36(3):420-433
pubmed: 29230885

Auteurs

Elizaveta Voynova (E)

Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.

Konstantin Kulebyakin (K)

Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.
Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Olga Grigorieva (O)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Ekaterina Novoseletskaya (E)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Natalia Basalova (N)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Natalia Alexandrushkina (N)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Mikhail Arbatskiy (M)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Maxim Vigovskiy (M)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Anna Sorokina (A)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Anna Zinoveva (A)

Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.

Elizaveta Bakhchinyan (E)

Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.

Natalia Kalinina (N)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Zhanna Akopyan (Z)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Vsevolod Tkachuk (V)

Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.

Pyotr Tyurin-Kuzmin (P)

Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.

Anastasia Efimenko (A)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.

Classifications MeSH